Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Morningside is a private investment group and venture capital firm founded in 1986 and based in Newton Centre, Massachusetts. The firm invests in companies built around novel science and technology, with activity spanning biotech, digital health, medtech, AI, and other innovation sectors. In life sciences, Morningside acts as an investor rather than an operating drug-development company, backing portfolio companies across multiple therapeutic areas and stages. It appears to be an active private investment organization with a long-term company-building approach and roots in the Chan family business network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Morningside Investments.